Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 10/20 | 0.50 |
| ▸ | MMP9 | P14780 | 9/20 | 0.50 |
| ▸ | MMP13 | P45452 | 3/20 | 0.47 |
| ▸ | MMP3 | P08254 | 2/20 | 0.47 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | ADAM17 | P78536 | 3/20 | 0.45 |
| ▸ | MMP14 | P50281 | 1/20 | 0.45 |
| ▸ | MMP1 | P03956 | 1/20 | 0.44 |
| ▸ | MMP7 | P09237 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6514467 | 1.00 | TDP1 (0.57) | TDP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL9221798 | 1.00 | TDP1 (0.57) | TDP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL10611069 | 0.92 | TDP1 (0.49) | TDP1MMP2MMP9MMP13MMP3 | |
| Imidazole SCHEMBL7269081 | 0.92 | TDP1 (0.49) | TDP1MMP2MMP9MMP13MMP3 | |
| Imidazole SCHEMBL28169637 | 0.92 | TDP1 (0.49) | TDP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL7382028 | 0.90 | TSHR (0.50) | TDP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL7335677 | 0.88 | KCNA5 (0.45) | TDP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL10586916 | 0.88 | TDP1 (0.44) | TDP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL10612379 | 0.87 | MMP9 (0.46) | TDP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL10914765 | 0.87 | MMP2 (0.48) | TDP1MMP2MMP9MMP13MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113698457-B | Preparation method of gonadorelin acetate | 上海丽珠制药有限公司 | 2024-06-11 | — | — | CN | claimed |
| EP-1029073-B1 | METHOD AND AGENT FOR DETERMINING DEAMINASE ACTIVITY | BIO MERIEUX (FR) | 2007-05-09 | — | — | EP | claimed |
| US-6733986-B1 | IMPORTANT IN MEDICINE, AGRIFOODS INDUSTRY, ENVIRONMENTAL CONTROL | BIO MERIEUX (FR) | 2004-05-11 | — | — | US | claimed |
| EP-1029073-A1 | METHOD AND AGENT FOR DETERMINING AN ENZYMATIC ACTIVITY SUCH AS DEAMINASE | BIO MERIEUX (FR) | 2000-08-23 | — | — | EP | claimed |
| WO-1999024604-A1 | METHOD AND AGENT FOR DETERMINING AN ENZYMATIC ACTIVITY SUCH AS DEAMINASE | BIO MERIEUX (FR) | 1999-05-20 | — | — | WO | claimed |
| CN-113698457-B | Preparation method of gonadorelin acetate | 上海丽珠制药有限公司 | 2024-06-11 | — | — | CN | disclosed |
| EP-1029073-B1 | METHOD AND AGENT FOR DETERMINING DEAMINASE ACTIVITY | BIO MERIEUX (FR) | 2007-05-09 | — | — | EP | disclosed |
| US-20050026827-A1 | Octapeptide bombesin analogs | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, SAS, A PARIS, FRANCE | 2005-02-03 | — | — | US | disclosed |
| US-6733986-B1 | IMPORTANT IN MEDICINE, AGRIFOODS INDUSTRY, ENVIRONMENTAL CONTROL | BIO MERIEUX (FR) | 2004-05-11 | — | — | US | disclosed |
| US-20030050436-A1 | Octapeptide bombesin analogs | BIOMEASURE INC., MASSACHUSETTS CORPORATION | 2003-03-13 | — | — | US | disclosed |
| US-6307017-B1 | Octapeptide bombesin analogs | BIOMEASURE, INCORPORATED | 2001-10-23 | — | — | US | disclosed |
| EP-1029073-A1 | METHOD AND AGENT FOR DETERMINING AN ENZYMATIC ACTIVITY SUCH AS DEAMINASE | BIO MERIEUX (FR) | 2000-08-23 | — | — | EP | disclosed |
| EP-0233838-A2 | Neurite-promoting factor and process for the manufacture thereof | INCYTE PHARMACEUTICALS, INC. (US) | 1987-08-26 | — | — | EP | disclosed |
| WO-1987004349-A1 | PEPTIDE ANALOGS | DELLARIA JOSEPH | 1987-07-30 | — | — | WO | disclosed |
| US-4605641-A | BRONCHODILATOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1986-08-12 | — | — | US | disclosed |
| EP-0188214-A2 | Novel growth hormone-releasing peptides and method of treating mammals therewith | The Administrators of The Tulane University Educational Fund (US) | 1986-07-23 | — | — | EP | disclosed |
| EP-0173481-A2 | Peptides | THE UPJOHN COMPANY (US) | 1986-03-05 | — | — | EP | disclosed |
| EP-0168042-A2 | Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them | TANABE SEIYAKU CO., LTD. (JP) | 1986-01-15 | — | — | EP | disclosed |
| EP-0136475-A2 | Novel growth hormone-releasing peptides and method of treating mammals therewith | The Administrators of The Tulane University Educational Fund (US) | 1985-04-10 | — | — | EP | disclosed |
| EP-0119153-A2 | Synthetic vaccines | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1984-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030050436-A1 | Octapeptide bombesin analogs | GRPR, GHRHR, VGF | TDP1 4151/4885MMP2 1708/4885MMP9 3199/4885 |
| US-20050026827-A1 | Octapeptide bombesin analogs | GRPR, VGF, GHRHR | TDP1 4219/4885MMP2 1954/4885MMP9 2896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.